AAAAAA

   
Results: 1-18 |
Results: 18
PHASE-II TRIAL OF OXALIPLATIN AS FIRST-LINE CHEMOTHERAPY IN METASTATIC COLORECTAL-CANCER PATIENTS
Authors: BECOUARN Y YCHOU M DUCREUX M BOREL C BERTHEAULTCVITKOVIC F SEITZ JF NASCA S NGUYEN TD PAILLOT B RAOUL JL DUFFOUR J FANDI A DUPONTANDRE G ROUGIER P
Citation: Y. Becouarn et al., PHASE-II TRIAL OF OXALIPLATIN AS FIRST-LINE CHEMOTHERAPY IN METASTATIC COLORECTAL-CANCER PATIENTS, Journal of clinical oncology, 16(8), 1998, pp. 2739-2744
EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL
Authors: GRIMALDI C BLEIBERG H GAY F MESSNER M ROUGIER P KOK TC CIRERA L CERVANTES A DEGREVE J PAILLOT B BUSET M NITTI D SAHMOUD T DUEZ N WILS J
Citation: C. Grimaldi et al., EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 411-417
CHEMOPREVENTION OF METACHRONOUS ADENOMAS OF THE LARGE-BOWEL - DESIGN AND INTERIM RESULTS OF A RANDOMIZED TRIAL OF CALCIUM AND FIBER
Authors: FAIVRE J COUILLAULT C KRONBORG O RATH U GIACOSA A DEOLIVEIRA H OBRADOR T OMORAIN C ANDREATTA R BUSET M CRESPON B FENGER K JUSTUM AM KERR G LEGOUX JL MARKS C MATEK W OWEN RW PAILLOT B PIARD F PIENKOWSKI P PIGNATELLE M PRADA A PUJOL J ROZEN P RICHTER F SEITZ JF STURNIOLO GC ZAMBELLI A
Citation: J. Faivre et al., CHEMOPREVENTION OF METACHRONOUS ADENOMAS OF THE LARGE-BOWEL - DESIGN AND INTERIM RESULTS OF A RANDOMIZED TRIAL OF CALCIUM AND FIBER, European journal of cancer prevention, 6(2), 1997, pp. 132-138
EFFICIENCY OF FOLLOW-UP STRATEGIES AFTER RADICAL SURGERY FOR COLONIC-CANCER (RSCC) - A DECISION-ANALYSIS
Authors: MICHEL P MERLE V PAILLOT B MAUILLON J DUEROTTE P CZERNICHOW P
Citation: P. Michel et al., EFFICIENCY OF FOLLOW-UP STRATEGIES AFTER RADICAL SURGERY FOR COLONIC-CANCER (RSCC) - A DECISION-ANALYSIS, European journal of cancer, 33, 1997, pp. 47-47
RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER
Authors: BLEIBERG H CONROY T PAILLOT B LACAVE AJ BLIJHAM G JACOB JH BEDENNE L NAMER M DEBESI P GAY F COLLETTE L SAHMOUD T
Citation: H. Bleiberg et al., RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER, European journal of cancer, 33(8), 1997, pp. 1216-1220
5-FLUOROURACIL (5-FU) CONTINUOUS INTRAVENOUS-INFUSION COMPARED WITH BOLUS ADMINISTRATION - FINAL RESULTS OF A RANDOMIZED TRIAL IN METASTATIC COLORECTAL-CANCER
Authors: ROUGIER P PAILLOT B LAPLANCHE A MORVAN F SEITZ JF REKACEWICZ C LAPLAIGE P JACOB J GRANDJOUAN S TIGAUD JM FABRI MC LUBOINSKI M DUCREUX M
Citation: P. Rougier et al., 5-FLUOROURACIL (5-FU) CONTINUOUS INTRAVENOUS-INFUSION COMPARED WITH BOLUS ADMINISTRATION - FINAL RESULTS OF A RANDOMIZED TRIAL IN METASTATIC COLORECTAL-CANCER, European journal of cancer, 33(11), 1997, pp. 1789-1793
COMPARISON BETWEEN ENDOSCOPIC AND SURGICAL SAMPLING FOR THE MEASUREMENT OF POTENTIAL DOUBLING TIME IN COLORECTAL-CANCER
Authors: MICHEL P HEMET J PARESY M MENARD JF LAQUERRIERE A SCOTTE M PAILLOT B PEILLON C DUCROTTE P
Citation: P. Michel et al., COMPARISON BETWEEN ENDOSCOPIC AND SURGICAL SAMPLING FOR THE MEASUREMENT OF POTENTIAL DOUBLING TIME IN COLORECTAL-CANCER, Cytometry, 29(3), 1997, pp. 273-278
DETECTION OF SOMATIC MUTATIONS OF P53 WITH A FUNCTIONAL TEST IN ESOPHAGEAL CANCER
Authors: CHIRON A FLAMAN JM MITCHEL P MARTIN C MOREAU V PAILLOT B FREBOURG T
Citation: A. Chiron et al., DETECTION OF SOMATIC MUTATIONS OF P53 WITH A FUNCTIONAL TEST IN ESOPHAGEAL CANCER, Gastroenterology, 112(4), 1997, pp. 548-548
IDENTIFICATION OF NOVEL GERMLINE HMLH1 MUTATIONS INCLUDING A 22-KB ALU-MEDIATED DELETION IN PATIENTS WITH FAMILIAL COLORECTAL-CANCER
Authors: MAUILLON J MICHEL P LIMACHER JM LATOUCHE JB CHARBONNIER F MARTIN C MOREAU V PAILLOT B FREBOURG T
Citation: J. Mauillon et al., IDENTIFICATION OF NOVEL GERMLINE HMLH1 MUTATIONS INCLUDING A 22-KB ALU-MEDIATED DELETION IN PATIENTS WITH FAMILIAL COLORECTAL-CANCER, Gastroenterology, 112(4), 1997, pp. 611-611
EFFICIENCY OF 4 FOLLOW-UP STRATEGIES AFTER RADICAL SURGERY FOR COLONIC-CANCER (RSCC) - A DECISION-ANALYSIS
Authors: MICHEL P MERLE V CHIRON A PAILLOT B DUCROTTE P HECKETSWEILER P CZERNICHOW P
Citation: P. Michel et al., EFFICIENCY OF 4 FOLLOW-UP STRATEGIES AFTER RADICAL SURGERY FOR COLONIC-CANCER (RSCC) - A DECISION-ANALYSIS, Gastroenterology, 112(4), 1997, pp. 615-615
FOTEMUSTINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER, A PHASE-II TRIAL FROM THE EORTC-GITCCG (EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP)
Authors: ROUGIER P VANPOTTELSBERGHE C KOK T PAILLOT B WAGENER T DEGREVE J FABRI MC GERARD B VANGLABBEKE M BLEIBERG H
Citation: P. Rougier et al., FOTEMUSTINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER, A PHASE-II TRIAL FROM THE EORTC-GITCCG (EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP), European journal of cancer, 32A(8), 1996, pp. 1432-1433
PHASE-II TRIAL OF VINORELBINE IN METASTATIC SQUAMOUS-CELL ESOPHAGEAL-CARCINOMA
Authors: CONROY T ETIENNE PL ADENIS A WAGENER DJT PAILLOT B FRANCOIS E BEDENNE L JACOB JH SEITZ JF BLEIBERG H VANPOTTELSBERGHE C VANGLABBEKE M DELGADO FM MERLE S WILS J
Citation: T. Conroy et al., PHASE-II TRIAL OF VINORELBINE IN METASTATIC SQUAMOUS-CELL ESOPHAGEAL-CARCINOMA, Journal of clinical oncology, 14(1), 1996, pp. 164-170
IDENTIFICATION OF NOVEL GERMLINE HMLH1 MUTATIONS INCLUDING A 22 KB ALU-MEDIATED DELETION IN PATIENTS WITH FAMILIAL COLORECTAL-CANCER
Authors: MAUILLON JL MICHEL P LIMACHER JM LATOUCHE JB DECHELOTTE P CHARBONNIER F MARTIN C MOREAU V METAYER J PAILLOT B FREBOURG T
Citation: Jl. Mauillon et al., IDENTIFICATION OF NOVEL GERMLINE HMLH1 MUTATIONS INCLUDING A 22 KB ALU-MEDIATED DELETION IN PATIENTS WITH FAMILIAL COLORECTAL-CANCER, Cancer research, 56(24), 1996, pp. 5728-5733
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
INCIDENCE OF RECTOSIGMOID ADENOMAS (RSA) IN A COHORT WITHOUT PRIOR PERSONAL OR FAMILIAL HISTORY OF COLORECTAL-CANCER (CRC) OR COLORECTAL ADENOMA (CRA)
Authors: PAILLOT B CZERNICHOW P MICHEL P QUEUNIET AM DAUBERT C
Citation: B. Paillot et al., INCIDENCE OF RECTOSIGMOID ADENOMAS (RSA) IN A COHORT WITHOUT PRIOR PERSONAL OR FAMILIAL HISTORY OF COLORECTAL-CANCER (CRC) OR COLORECTAL ADENOMA (CRA), Gastroenterology, 108(4), 1995, pp. 522-522
PHASE-II STUDY OF SEQUENTIAL HIGH-DOSE METHOTREXATE (MTX) AND 5-FLUOROURACIL (F) ALTERNATED WITH EPIRUBICIN (E) AND CISPLATIN (P) [FEMTX-P]IN ADVANCED GASTRIC-CANCER
Authors: ROELOFS EJM WAGENER DJT CONROY T WILS J BURGHOUTS JT FICKERS M DEGRAEFF A LALISANG F PAILLOT B
Citation: Ejm. Roelofs et al., PHASE-II STUDY OF SEQUENTIAL HIGH-DOSE METHOTREXATE (MTX) AND 5-FLUOROURACIL (F) ALTERNATED WITH EPIRUBICIN (E) AND CISPLATIN (P) [FEMTX-P]IN ADVANCED GASTRIC-CANCER, Annals of oncology, 4(5), 1993, pp. 426-428
EXTENDED NECROSIS OF THE ESOPHAGEAL WALL AFTER PHOTODYNAMIC THERAPY -REPORT OF 2 CASES
Authors: HOCHAIN P DUCROTTE P TOUCHAIS JY PAILLOT B HECKETSWEILER P
Citation: P. Hochain et al., EXTENDED NECROSIS OF THE ESOPHAGEAL WALL AFTER PHOTODYNAMIC THERAPY -REPORT OF 2 CASES, Lasers in medical science, 8(2), 1993, pp. 147-150
ABDOMINAL RADIOTHERAPY IS A CAUSE FOR CHRONIC-PANCREATITIS
Authors: LEVY P MENZELXHIU A PAILLOT B BRETAGNE JF FLEJOU JF BERNADES P
Citation: P. Levy et al., ABDOMINAL RADIOTHERAPY IS A CAUSE FOR CHRONIC-PANCREATITIS, Gastroenterology, 105(3), 1993, pp. 905-909
Risultati: 1-18 |